Search for: "Astrazeneca" Results 201 - 220 of 1,244
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Mar 2010, 6:05 am by John J. Cord
AstraZeneca Pharmaceuticals LP is now focusing on the drug manufacturer’s advertising strategy. [read post]
19 Mar 2010, 4:10 am by Mark Zamora
AstraZeneca officials properly warned a Vietnam veteran’s doctors about the diabetes risk posed by its Seroquel antipsychotic drug, a jury ruled in the first case over the medicine to go to trial.A state court jury in New Brunswick, New Jersey, deliberated a total of six hours over two days before finding the company’s warnings to Ted Baker’s doctors absolved AstraZeneca of responsibility for his injuries. [read post]
21 Aug 2008, 4:57 am
Jones, the District Court judge sitting in the Southern District of New York who has handled the consolidated infringement actions brought by AstraZeneca under 35 U.S.C. [read post]
17 Dec 2008, 5:19 pm
Fisk of Bloomberg.com report AstraZeneca's release of its internal studies that suggested causal links between Seroquel and "diabetes and related conditions. [read post]
5 Oct 2023, 6:21 am by Levin Papantonio
 Levin Papantonio Rafferty (LPR) Attorneys Troy Rafferty and Cameron Stephenson announced a settlement victory involving thousands of lawsuits claiming AstraZeneca's heartburn drugs, Nexium and Prilosec, caused chronic kidney injuries. [read post]
9 Sep 2015, 6:11 am by Mary Jane Wilmoth
  Of that amount, AstraZeneca will pay roughly $26.7 million, plus interest, to the United States, and the remainder to states participating in the settlement. [read post]
2 Mar 2009, 5:46 am
According to documents that were just unsealed in a U.S. federal court case showed AstraZeneca knew about the risk of weight gain and diabetes in 2000. [read post]
12 Jun 2008, 3:22 am
Cir. 2008) Yesterday, the Court of Appeals for the Federal Circuit affirmed a June 2007 district court decision finding that Mylan's generic version of Prilosec (omeprazole) does not infringe two AstraZeneca patents, U.S. [read post]
23 Apr 2009, 3:48 am
  AstraZeneca is currently under review by the FDA to have the drug’s use expanded to include patients of depression and anxiety. [read post]
2 Feb 2009, 9:00 pm
Id. at 7.AstraZeneca moved, fourth, to exclude evidence about three letters the FDA's Division of Drug Marketing, Advertising, and Communications (DDMAC) sent to AstraZeneca discussing certain of AstraZeneca's promotional materials. [read post]
8 Dec 2016, 2:00 am by Linda O'Brien
Linda O'BrienCCHPurchasers of AstraZeneca LP’s heartburn medication Nexium were not entitled to a new trial to their challenge of “reverse payment” agreements between AstraZeneca and Ranbaxy Pharmaceuticals that allegedly blocked the entry of a generic version of the drug, the U.S. [read post]
2 Dec 2011, 5:36 am by Lawrence B. Ebert
There is no ques- tion that AstraZeneca appreciated that AstraZeneca’s drug contained an “amount” of crospovidone. [read post]
25 Oct 2017, 12:59 am by Miquel Montañá
Functionality and Scope of Protection by edited by Chris Carani€ 199 3D Printing, Intellectual Property and Innovation: Insights from Law and Technology by Rosa Maria Ballardini, Marcus Norrgård, Jouni Partanen€ 128 The Unitary Patent and the Unified Patent Court by Pieter Callens & Sam Granata€ 150 … [read post]
28 Apr 2010, 7:14 am by Mark Zamora
From the DOJ Press Statement:AstraZeneca LP and AstraZeneca Pharmaceuticals LP will pay $520 million to resolve allegations that AstraZeneca illegally marketed the anti-psychotic drug Seroquel for uses not approved as safe and effective by the Food and Drug Administration (FDA), the Departments of Justice and Health and Human Services’ Health Care Fraud Enforcement Action Team (HEAT) announced today. [read post]
8 Dec 2021, 8:52 am by Lawrence B. Ebert
The outcome AstraZeneca AB and AstraZeneca Pharmaceuticals LP (collectively, “AstraZeneca”) sued Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P. [read post]
9 Dec 2021, 7:15 am by Logan Murr
The decision relates to AstraZeneca AB’s and AstraZeneca Pharmaceuticals LP’s (collectively “AstraZeneca”) lawsuit against Mylan and Kindeva Drug Delivery LP (collectively “Mylan”) for infringing all claims of U.S. [read post]
6 Nov 2019, 3:18 pm by Alaric Dearment - MedCity News
The drug is also the subject of a $7 billion partnership with AstraZeneca. [read post]
5 Sep 2012, 9:45 am by JA Hodnicki
ABSTRACT: If the Court of Justice follows the Advocate General's advice and upholds the General Court's judgment in AstraZeneca, this... [read post]